Keywords: abt-378/r, pediatric, data, abbott, presented, first, its
ABT-378/r pediatric data
Article | 10 July 2000
Abbott presented the first pediatric data on its investigational HIVprotease inhibitor, ABT-378/r (lopinavir/ritonavir), at the International AIDS Conference. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
